SCHEMBL2012484

SCHEMBL2012484

C=Cc1ccc(C(=O)OC)c(N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 2/20 0.35
TUBB P07437 2/20 0.35
TUBA3C P0DPH7 2/20 0.35
TUBA1B P68363 2/20 0.35
TUBA4A P68366 2/20 0.35
TUBB4B P68371 2/20 0.35
TUBB3 Q13509 2/20 0.35
TUBB2A Q13885 2/20 0.35
TUBB8 Q3ZCM7 2/20 0.35
TUBA3E Q6PEY2 2/20 0.35
TUBA1A Q71U36 2/20 0.35
TUBA1C Q9BQE3 2/20 0.35
TUBB6 Q9BUF5 2/20 0.35
TUBB2B Q9BVA1 2/20 0.35
TUBB1 Q9H4B7 2/20 0.35
ATR Q13535 1/20 0.35
SYK P43405 1/20 0.32
CSNK2A1 P68400 1/20 0.31
KDM4E B2RXH2 1/20 0.31
CA12 O43570 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2009130 0.89 ATR (0.38) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL2010511 0.85 KDM4E (0.40) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL2010512 0.85 KDM4E (0.40) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL25277445 0.80 NPSR1 (0.33) ATRALDH1A1LMNA
SCHEMBL31523568 0.80 TUBB4A (0.36) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL10325135 0.79 NPSR1 (0.33) ATRSYKPDPK1ALDH1A1
SCHEMBL25227083 0.77 NPSR1 (0.33) ATRPDPK1ALDH1A1
SCHEMBL25276684 0.74 ATR (0.34) ATRSYKPDPK1ALDH1A1
SCHEMBL25277444 0.72 NPSR1 (0.31) ALDH1A1LMNA
SCHEMBL24834592 0.72 NPSR1 (0.44) KDM4ECA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3560923-B1 ANTI PARASITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC (US) 2021-05-05 EP disclosed
EP-3560923-A1 ANTI PARASITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME Boehringer Ingelheim Animal Health USA Inc. (US) 2019-10-30 EP disclosed
EP-3078664-B1 ANTIPARASITIC DIHYDROAZOLE COMPOSITIONS MERIAL INC (US) 2019-02-20 EP disclosed
US-9776999-B2 Antiparisitic dihydroazole compounds and compositions comprising same MERIAL INC. (US) 2017-10-03 US disclosed
US-20170022197-A1 ANTIPARISITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME MERIAL, INC. (US) 2017-01-26 US disclosed
EP-3078664-A1 ANTIPARASITIC DIHYDROAZOLE COMPOSITIONS Merial Inc. (US) 2016-10-12 EP disclosed
US-9376434-B2 Antiparisitic dihydroazole compounds and compositions comprising same MERIAL INC. (US) 2016-06-28 US disclosed
EP-2513104-B1 ANTIPARASITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME MERIAL INC (US) 2016-03-16 EP disclosed
US-20150183785-A1 ANTIPARISITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME MERIAL, INC. (US) 2015-07-02 US disclosed
US-8980893-B2 Antiparisitic dihydroazole compounds and compositions comprising same MERIAL, INC. (US) 2015-03-17 US disclosed
US-20140315794-A1 ANTIPARISITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME MERIAL LIMITED (US) 2014-10-23 US disclosed
US-8618126-B2 Antiparisitic dihydroazole compounds and compositions comprising same MERIAL LIMITED (US) 2013-12-31 US disclosed
EP-2513104-A1 ANTI PARASITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME Merial Limited (US) 2012-10-24 EP disclosed
WO-2011075591-A1 ANTI PARASITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME MERIAL LIMITED (US) 2011-06-23 WO disclosed
US-20110152312-A1 ANTIPARISITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME MERIAL, INC. 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140315794-A1 ANTIPARISITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME DDT, CYP1A1, CYP1A2 TUBB4A 515/4885TUBB 417/4885TUBA3C 70/4885
US-20110152312-A1 ANTIPARISITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME DDT, CYP1A1, CYP1A2 TUBB4A 515/4885TUBB 417/4885TUBA3C 70/4885
US-20170022197-A1 ANTIPARISITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME DDT, CYP1A1, CYP1A2 TUBB4A 515/4885TUBB 417/4885TUBA3C 70/4885
US-20150183785-A1 ANTIPARISITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME DDT, CYP1A1, CYP1A2 TUBB4A 515/4885TUBB 417/4885TUBA3C 70/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.